| Pharmaceutical active ingredients: |
| Procainamide Hydrochloride |
| Available forms, composition and doses of Procan SR: |
| Tablets, Extended Release; Oral; Procainamide Hydrochloride 250 mgTablets, Extended Release; Oral; Procainamide Hydrochloride 500 mgTablets, Extended Release; Oral; Procainamide Hydrochloride 750 mg |
| Procan SR medical category: |
| Human:Class IA antiarrythmics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01BA02 - Procainamide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerERFAParkedale PharmaceuticalsParke-Davis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Procainamide | Procainamide Hydrochloride | Vangard Laboratories |
| Procainamide | Procainamide Hydrochloride | Warner Chilcott |
| Procainamide | Procainamide Hydrochloride | Watson Pharmaceuticals |
| Procamide | Procainamide Hydrochloride | Zambon |
| Procan | Procainamide Hydrochloride | Pfizer; Parke-Davis |
| Procanbid | Procainamide Hydrochloride | King Pharmaceuticals; Monarch Pharmaceuticals |
| Procapan | Procainamide Hydrochloride | Panray |
| Pronestyl | Procainamide Hydrochloride | Bristol-Myers Squibb; Apothecon; DKSH; Institute of Pharmaceutical Research and Technology; Sarabhai Piramal Pharma |
| Pronestyl-SR | Procainamide Hydrochloride | Bristol-Myers Squibb; Apothecon |
| Allocaine | Procaine | Unidentified Pharmaceutical Company |